disease-modifying antirheumatic drugs

All patients in the group were receiving disease-modifying antirheumatic drugs and were clinically stable.

Five-year follow-up of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year.

Some disease-modifying antirheumatic drugs (DMARDs) that have been around for decades.

Disease-modifying antirheumatic drugs (DMARDs) are usually started within 3 months of your diagnosis.

Disease-modifying antirheumatic drugs (DMARDs) slow or halt the progress of the disease.

Antimalarials are used either alone or in combination with other disease-modifying antirheumatic drugs (DMARDs).

To protect joints from damage, doctors turn to disease-modifying antirheumatic drugs (DMARDs).

It belongs to a class of medications known as disease-modifying antirheumatic drugs (DMARDs).

For many patients, the pain and joint destruction the disease causes can be managed with medications such as disease-modifying antirheumatic drugs, anti-inflammatory drugs, and steroids.

Also, disease-modifying antirheumatic drugs (DMARDs) such as methotrexate may be helpful.

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

Biologics - and other disease-modifying antirheumatic drugs (DMARDs) - have revolutionized the approach.

Medicines called disease-modifying antirheumatic drugs (DMARDs) can slow or sometimes prevent joint destruction.

Methotrexate and etanercept are disease-modifying antirheumatic drugs (DMARDs).

Disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, which can help relieve joint pain and dry skin.

Disease-modifying antirheumatic drugs (DMARD) are the primary treatment for RA.

Gold is not usually the first treatment given to people with rheumatoid arthritis, since methotrexate and other disease-modifying antirheumatic drugs (DMARDs) are available.

Disease-modifying antirheumatic drugs (DMARDs) help slow or stop progression of RA.

These drugs are called disease-modifying antirheumatic drugs (DMARDs), and they are an important part of an overall treatment plan.

Sometimes disease-modifying antirheumatic drugs (DMARDs) can reduce the size of RA nodules.

Therefore, it has been used in autoimmune diseases where disease-modifying antirheumatic drugs (DMARDs) have been ineffective.

Synovectomy may be considered if significant pain persists after 6 to 12 months of drug treatment, including the use of disease-modifying antirheumatic drugs (DMARDs).

The goal today is suppression of the disease and prevention of progressive joint destruction by treating patients early with synthetic or biologic agents called disease-modifying antirheumatic drugs.

Unlike DMARDs (disease-modifying antirheumatic drugs), these medicines don't slow down the joint damage that rheumatoid arthritis can cause.

All had early rheumatoid arthritis, with an average of less than four months since diagnosis, and had not yet received disease-modifying antirheumatic drugs (DMARDs).